|
STK39 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.85327317328665E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.25810045609387E-10 |
| Normal-vs-Stage2 |
1.258040E-03 |
| Normal-vs-Stage3 |
4.32799999999789E-05 |
| Normal-vs-Stage4 |
1.264180E-02 |
| Stage1-vs-Stage2 |
2.962000E-01 |
| Stage1-vs-Stage3 |
5.068400E-01 |
| Stage1-vs-Stage4 |
7.063400E-01 |
| Stage2-vs-Stage3 |
6.887800E-01 |
| Stage2-vs-Stage4 |
7.392400E-01 |
| Stage3-vs-Stage4 |
9.594800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.00313115989093E-12 |
| Normal-vs-AfricanAmerican |
2.23630000073527E-08 |
| Normal-vs-Asian |
1.217350E-01 |
| Caucasian-vs-AfricanAmerican |
6.240600E-01 |
| Caucasian-vs-Asian |
7.311200E-01 |
| AfricanAmerican-vs-Asian |
8.493600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.86399809318527E-12 |
| Normal-vs-Female |
3.58079998985517E-09 |
| Male-vs-Female |
6.818400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.8407699999945E-05 |
| Normal-vs-Extreme_Weight |
3.56170000048728E-07 |
| Normal-vs-Obese |
8.76519999915004E-08 |
| Normal-vs-Extreme_Obese |
7.140100E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.493800E-01 |
| Normal_Weight-vs-Obese |
6.996000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.238800E-01 |
| Extreme_Weight-vs-Obese |
4.287200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.628400E-01 |
| Obese-vs-Extreme_Obese |
6.580800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.753400E-04 |
| Normal-vs-Age(41-60Yrs) |
4.40210090602022E-11 |
| Normal-vs-Age(61-80Yrs) |
2.288600420286E-10 |
| Normal-vs-Age(81-100Yrs) |
1.167640E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.615800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.475620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.094400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.955400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.891400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.335400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.81750236661583E-11 |
| Normal-VS-Type2 PRCC |
3.38460000026686E-07 |
| Normal-VS-KIRP CIMP |
2.004800E-04 |
| Normal-VS-Unclassified PRCC |
4.21640000000112E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.403390E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.28270000030606E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
8.436000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.044260E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.576240E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.72902999999724E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.89400000000428E-05 |
| Normal-vs-N1 |
3.72880000000242E-05 |
| Normal-vs-N2 |
2.574200E-01 |
| N0-vs-N1 |
1.814030E-02 |
| N0-vs-N2 |
4.044200E-01 |
| N1-vs-N2 |
6.103600E-01 |
|
|
